Author: Topaktaş, Ramazan; Tokuç, Emre; Kutluhan, Musab Ali; Akyüz, Mehmet; Karabay, Emre; Çalışkan, Selahattin
Title: Clinical features and outcomes of COVIDâ€19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases Cord-id: 0twn98s4 Document date: 2020_6_7
ID: 0twn98s4
Snippet: AIM: A worldwide pandemic of coronavirus disease 2019 (COVIDâ€19) which emerged in China in December 2019 affects the world very seriously. We aimed to evaluate the benign prostatic hyperplasia (BPH) patients who were admitted and treated to our hospital due to COVIDâ€19. METHODS: Between March 18, 2020 and April 5, 2020, 18 patients admitted with COVIDâ€19 who has BPH and are using medication for this were included in the study and analyzed retrospectively. Diagnosis was confirmed by COVIDâ€
Document: AIM: A worldwide pandemic of coronavirus disease 2019 (COVIDâ€19) which emerged in China in December 2019 affects the world very seriously. We aimed to evaluate the benign prostatic hyperplasia (BPH) patients who were admitted and treated to our hospital due to COVIDâ€19. METHODS: Between March 18, 2020 and April 5, 2020, 18 patients admitted with COVIDâ€19 who has BPH and are using medication for this were included in the study and analyzed retrospectively. Diagnosis was confirmed by COVIDâ€19 nucleic acid test by sampling sputum or nasopharyngeal swab. Standard COVIDâ€19 treatment protocol determined by our Ministry of Health was applied to all patients according to their risk groups. Epidemiological, clinical, radiological features, additional diseases, laboratory tests, complications and outcome data of all patients were recorded. RESULTS: Mean age of patients was 59.6 (range: 56â€73). As the mode of transmission, 10 (55.5%) of patients were infected in hospital, 5 (27.7%) patients had a relative with COVIDâ€19 and 3 (16,6%) was unknown. During followâ€up, 2 (11.1%) patients were transferred to intensive care unit (ICU). One of these patients dramatically progressed and died. Patients who survived and were not transferred to ICU had lesser comorbidities and were relatively young. Mean duration of hospitalization was 14.2 days (range 12â€19). CONCLUSION: We think that COVIDâ€19 patients with BPH had a low mortality rate and did not have a poor prognosis in this patient group. It is crucial to take comprehensive preventive measures to control COVIDâ€19 transmission via hospital route.
Search related documents:
Co phrase search for related documents- acute ards and low lymphocyte count: 1, 2
- acute ards and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards and low mortality rate: 1, 2, 3, 4
- acute ards and low number: 1
- acute ards cardiac injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute ards respiratory distress syndrome and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute ards respiratory distress syndrome and low lymphocyte count: 1, 2
- acute ards respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- acute ards respiratory distress syndrome and low mortality rate: 1, 2, 3, 4
- acute ards respiratory distress syndrome and low number: 1
- acute cardiac injury acute liver injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute cardiac injury acute liver injury and low lymphocyte count: 1
- acute cardiac injury acute liver injury and low mortality: 1
- acute cardiac injury and liver injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute cardiac injury and low lymphocyte count: 1
- acute cardiac injury and low mortality: 1
- acute kidney injury and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- acute kidney injury and low mortality rate: 1
- acute kidney injury and low number: 1
Co phrase search for related documents, hyperlinks ordered by date